Not Tagged
biontech,roche
['pancreatic', 'immunogen', 'biontech', 'biontech_group']
preliminary ph1 data from our and s individualized #mrna based cancer vaccine program (bnt122 in our pipeline) presented at #asco22. the data in patients with pancreatic cancer showed a favorable safety profile &amp; was highly immunogenic in 8/16. 
Our vision is to harness the power of the immune system to develop novel therapies based on groundbreaking R&D with cutting-edge technologies $BNTX